| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
116,283 |
102,604 |
$4.26M |
| 87428 |
|
38,699 |
35,453 |
$2.12M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
37,681 |
31,170 |
$1.89M |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
68,122 |
61,399 |
$540K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
24,824 |
15,479 |
$272K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
16,307 |
7,025 |
$151K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
3,746 |
3,167 |
$139K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
7,707 |
6,755 |
$135K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,101 |
1,839 |
$132K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,962 |
3,663 |
$127K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,729 |
1,547 |
$103K |
| 90834 |
Psychotherapy, 45 minutes with patient |
2,677 |
2,141 |
$88K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,312 |
1,159 |
$80K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
895 |
811 |
$51K |
| 90791 |
Psychiatric diagnostic evaluation |
796 |
717 |
$42K |
| 87807 |
|
3,237 |
3,016 |
$26K |
| 90832 |
Psychotherapy, 30 minutes with patient |
968 |
810 |
$25K |
| 99215 |
Prolong outpt/office vis |
374 |
321 |
$21K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
216 |
176 |
$14K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
288 |
269 |
$11K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
320 |
294 |
$7K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
142 |
115 |
$7K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
4,428 |
3,379 |
$6K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
9,017 |
6,978 |
$6K |
| 3008F |
|
7,980 |
6,428 |
$5K |
| 81003 |
|
3,983 |
3,462 |
$5K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
24 |
23 |
$3K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
28 |
26 |
$2K |
| 90670 |
|
488 |
407 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
828 |
632 |
$1K |
| 1111F |
|
80 |
50 |
$740.00 |
| 90677 |
|
532 |
487 |
$657.72 |
| 76536 |
|
13 |
13 |
$597.57 |
| 1159F |
|
75 |
47 |
$510.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
87 |
81 |
$509.21 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
37 |
32 |
$438.89 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
68 |
63 |
$374.05 |
| 90698 |
|
196 |
170 |
$335.68 |
| 81025 |
|
61 |
52 |
$215.86 |
| 71046 |
Radiologic examination, chest; 2 views |
12 |
12 |
$178.28 |
| 90686 |
|
17 |
14 |
$45.44 |
| J0945 |
Injection, brompheniramine maleate, per 10 mg |
199 |
173 |
$44.48 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
116 |
37 |
$40.29 |
| 3077F |
|
12 |
12 |
$20.00 |
| 90651 |
|
96 |
67 |
$0.00 |
| 90619 |
|
17 |
12 |
$0.00 |
| 90697 |
|
51 |
51 |
$0.00 |
| 90680 |
|
151 |
129 |
$0.00 |
| 4037F |
|
15 |
12 |
$0.00 |
| 90710 |
|
44 |
39 |
$0.00 |
| 90633 |
|
70 |
63 |
$0.00 |
| 90715 |
|
15 |
14 |
$0.00 |
| 90734 |
|
12 |
12 |
$0.00 |